Seeking Alpha

  Arrowhead Research Corporation (ARWR) - NASDAQ

ARWR vs. ETF Alternatives
Company Description
Arrowhead Research Corp is engaged in developing novel drugs to treat intractable diseases by silencing the genes. The Company's drug candidate ARC-520 is designed to treat chronic hepatitis B infection.
Sector: Healthcare
Industry: Biotechnology
Country: United States